Topics

"I-STAND R21: Reducing Sedentary Time in Obese Older Adults" Drugs and Medication Database

20:08 EDT 4th April 2020 | BioPortfolio

Here are the most relevant "I-STAND R21: Reducing Sedentary Time in Obese Older Adults" Drugs and Medications that we have found in our database.

More Information about "I-STAND R21: Reducing Sedentary Time in Obese Older Adults" on BioPortfolio

We have published hundreds of I-STAND R21: Reducing Sedentary Time in Obese Older Adults news stories on BioPortfolio along with dozens of I-STAND R21: Reducing Sedentary Time in Obese Older Adults Clinical Trials and PubMed Articles about I-STAND R21: Reducing Sedentary Time in Obese Older Adults for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of I-STAND R21: Reducing Sedentary Time in Obese Older Adults Companies in our database. You can also find out about relevant I-STAND R21: Reducing Sedentary Time in Obese Older Adults Drugs and Medications on this site too.

Showing "STAND Reducing Sedentary Time Obese Older Adults" Drugs and Medications, all 3

Possibly Relevant

Goniotaire [altaire pharmaceuticals inc.]

Goniotaire

Humira [abbvie inc.]

These highlights do not include all the information needed to use HUMIRA safely and effectively. See full prescribing information for HUMIRA. HUMIRA (adalimumab) injection, for subcutaneous useInitial U.S. Approval: 2002

Humira [a-s medication solutions]

These highlights do not include all the information needed to use HUMIRA safely and effectively. See full prescribing information for HUMIRA. HUMIRA (adalimumab) injection, for subcutaneous useInitial U.S. Approval: 2002



Quick Search